Sagimet Biosciences Inc. (hereinafter referred to as "Sagimet") announced that its latest research progress will be presented at the "Fueling MASH: Metabolic Drivers and Inflammatory Interactions" Keystone Symposium through poster and oral presentations.

This conference will bring together top experts in the field to jointly discuss the latest scientific discoveries related to metabolic dysfunction-associated steatohepatitis (MASH). Meanwhile, the company also disclosed that, in accordance with Nasdaq Listing Rule 5635(c)(4), it has granted an inducement equity award to new employees. Such awards are a common practice among biotechnology companies, aimed at attracting high-quality talent and advancing the company's research and development pipeline.